Jennifer Christopher, N.P

NPI: 1962722769
Total Payments
$17.62
2024 Payments
$17.62
Companies
1
Transactions
1
Medicare Patients
1,200
Medicare Billing
$221,235

Payment Breakdown by Category

Food & Beverage$17.62 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $17.62 1 100.0%

Top Paying Companies

Company Total Records Latest Year
Averitas Pharma Inc. $17.62 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $17.62 1 Averitas Pharma Inc. ($17.62)

All Payment Transactions

1 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/22/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $17.62 General
Category: PAIN MANAGEMENT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 149 608 $77,865 $37,187
2022 6 287 1,124 $109,220 $56,245
2021 8 358 1,203 $123,920 $66,380
2020 8 406 1,431 $143,319 $61,422
Total Patients
1,200
Total Services
4,366
Medicare Billing
$221,235
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 95 538 $75,320 $36,334 48.2%
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes Office 2023 22 23 $1,035 $372.68 36.0%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 19 19 $418.00 $269.99 64.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 13 28 $1,092 $210.48 19.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 113 736 $103,040 $53,760 52.2%
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes Office 2022 56 56 $2,520 $1,273 50.5%
G0444 Annual depression screening, 15 minutes Office 2022 49 49 $1,078 $711.02 66.0%
96372 Injection of drug or substance under skin or into muscle Office 2022 31 52 $2,028 $432.84 21.3%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2022 24 138 $414.00 $58.41 14.1%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2022 14 93 $139.50 $9.16 6.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 130 822 $115,080 $62,178 54.0%
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes Office 2021 70 72 $3,240 $1,711 52.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 18 20 $2,000 $1,118 55.9%
G0444 Annual depression screening, 15 minutes Office 2021 61 61 $1,342 $921.10 68.6%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 29 44 $1,716 $351.88 20.5%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2021 14 17 $170.00 $63.65 37.4%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2021 21 81 $243.00 $27.30 11.2%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2021 15 86 $129.00 $8.52 6.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 158 955 $133,660 $57,502 43.0%
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes Office 2020 64 65 $2,925 $1,559 53.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 11 21 $2,100 $944.65 45.0%
G0444 Annual depression screening, 15 minutes Office 2020 61 61 $1,342 $895.57 66.7%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 41 65 $2,535 $387.35 15.3%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2020 23 29 $290.00 $97.05 33.5%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2020 25 76 $228.00 $27.08 11.9%

About Jennifer Christopher, N.P

Jennifer Christopher, N.P is a Primary Care healthcare provider based in Athens, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1962722769.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Christopher, N.P has received a total of $17.62 in payments from pharmaceutical and medical device companies, with $17.62 received in 2024. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($17.62).

As a Medicare-enrolled provider, Christopher has provided services to 1,200 Medicare beneficiaries, totaling 4,366 services with total Medicare billing of $221,235. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Primary Care
  • Location Athens, AL
  • Active Since 06/03/2010
  • Last Updated 10/25/2023
  • Taxonomy Code 363LP2300X
  • Entity Type Individual
  • NPI Number 1962722769

Products in Payments

  • QUTENZA (Drug) $17.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Primary Care Doctors in Athens